Please assess the completion status of the following clinical trial:

Trial Title: Remote Ischemic Preconditioning Living Donor Renal Transplant Protocol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* \> OR = 19 years of age receiving a living donor renal transplant (treatment control group) and their donors (control group donors)~Exclusion Criteria:~* \< 19 years of age~* No safe extremity to place tourniquet~* Patients with previous muscle, vascular, or nerve injury to an extremity,~* Patients with only one available extremity that has an arteriovenous fistula~* Patients who are hemodialysis dependent who have not received hemodialysis in the past 4 days~* Paraplegic/quadriplegic patients~* Active pathologic cutaneous lesions on extremities~* Patients with a history of tourniquet pain or complex regional pain syndrome (CRPS)~* Pregnant patients

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Treatment Group (Type: EXPERIMENTAL): The treatment will receive 200 mmHg of pressure from a Zimmer automatic tourniquet system (ATS) for three 5 minute intervals.
- Control Group (Type: EXPERIMENTAL): Our control group will receive 20 mmHg of pressure from a Zimmer automatic tourniquet system (ATS) for three 5 minute intervals.

Based on this trial design, predict the completion outcome and termination type (if applicable).